ResMed | RMD - Sales Revenues

Stock Price
266.80
Daily Change
3.77 1.43%
Monthly
7.07%
Yearly
12.49%
Q1 Forecast
250.35

ResMed reported $1.4B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Ansell USD 834.4M 49.5M Jun/2024
AtriCure USD 134.3M 1.8M Sep/2025
Baxter International USD 2.84B 30M Sep/2025
Cochlear AUD 585.65M 586.15M Jun/2025
Cooper Companies USD 1.07B 4.9M Sep/2025
CSL USD 3.54B 4.68B Jun/2025
Dexcom USD 1.21B 50M Sep/2025
Edwards Lifesciences USD 1.55B 20M Sep/2025
Fisher Paykel Healthcare NZD 1.1B 21.3M Dec/2025
Globus Medical USD 769M 23.7M Sep/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Insulet USD 706.3M 57.2M Sep/2025
Integra LifeSciences USD 402.06M 13.54M Sep/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
Masimo USD 371.5M 600K Sep/2025
Medtronic USD 8.96B 383M Sep/2025
Philips EUR 4.3B 38M Sep/2025
Ramsay Health Care AUD 9.29B 32.2M Dec/2025
ResMed USD 1.4B 100M Dec/2025
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Sonic Healthcare AUD 4.98B 311M Jun/2025
Steris USD 1.5B 470M Dec/2025
Teleflex USD 913M 132.11M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025